Atopic Dermatitis

Epidemiology and Pathogenesis Update

Lawrence F. Eichenfield, Charles N. Ellis, Anthony J. Mancini, Amy S. Paller, Eric Simpson

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The prevalence of atopic dermatitis (AD) has increased markedly in the United States over the past 5 decades, with current reports varying from 10% to 20% prevalence in US children, and new diagnoses are estimated at almost 11% per year. Recent research in AD pathophysiology and pathogenesis has demonstrated that AD is associated with epidermal barrier dysfunction and that mutations in the filaggrin gene are implicated in barrier defects. These discoveries hold promise for future breakthroughs in the diagnosis and management of AD.

Original languageEnglish (US)
JournalSeminars in Cutaneous Medicine and Surgery
Volume31
Issue number3 SUPPL.
DOIs
StatePublished - Sep 2012

Fingerprint

Atopic Dermatitis
Epidemiology
Mutation
Research
Genes

Keywords

  • Atopic dermatitis pathogenesis
  • Barrier defects
  • Epidermal skin barrier
  • Filaggrin gene

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Atopic Dermatitis : Epidemiology and Pathogenesis Update. / Eichenfield, Lawrence F.; Ellis, Charles N.; Mancini, Anthony J.; Paller, Amy S.; Simpson, Eric.

In: Seminars in Cutaneous Medicine and Surgery, Vol. 31, No. 3 SUPPL., 09.2012.

Research output: Contribution to journalArticle

Eichenfield, Lawrence F. ; Ellis, Charles N. ; Mancini, Anthony J. ; Paller, Amy S. ; Simpson, Eric. / Atopic Dermatitis : Epidemiology and Pathogenesis Update. In: Seminars in Cutaneous Medicine and Surgery. 2012 ; Vol. 31, No. 3 SUPPL.
@article{940a919d58e74abfb3bd9251af8affce,
title = "Atopic Dermatitis: Epidemiology and Pathogenesis Update",
abstract = "The prevalence of atopic dermatitis (AD) has increased markedly in the United States over the past 5 decades, with current reports varying from 10{\%} to 20{\%} prevalence in US children, and new diagnoses are estimated at almost 11{\%} per year. Recent research in AD pathophysiology and pathogenesis has demonstrated that AD is associated with epidermal barrier dysfunction and that mutations in the filaggrin gene are implicated in barrier defects. These discoveries hold promise for future breakthroughs in the diagnosis and management of AD.",
keywords = "Atopic dermatitis pathogenesis, Barrier defects, Epidermal skin barrier, Filaggrin gene",
author = "Eichenfield, {Lawrence F.} and Ellis, {Charles N.} and Mancini, {Anthony J.} and Paller, {Amy S.} and Eric Simpson",
year = "2012",
month = "9",
doi = "10.1016/j.sder.2012.07.002",
language = "English (US)",
volume = "31",
journal = "Seminars in Cutaneous Medicine and Surgery",
issn = "1085-5629",
publisher = "W.B. Saunders Ltd",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Atopic Dermatitis

T2 - Epidemiology and Pathogenesis Update

AU - Eichenfield, Lawrence F.

AU - Ellis, Charles N.

AU - Mancini, Anthony J.

AU - Paller, Amy S.

AU - Simpson, Eric

PY - 2012/9

Y1 - 2012/9

N2 - The prevalence of atopic dermatitis (AD) has increased markedly in the United States over the past 5 decades, with current reports varying from 10% to 20% prevalence in US children, and new diagnoses are estimated at almost 11% per year. Recent research in AD pathophysiology and pathogenesis has demonstrated that AD is associated with epidermal barrier dysfunction and that mutations in the filaggrin gene are implicated in barrier defects. These discoveries hold promise for future breakthroughs in the diagnosis and management of AD.

AB - The prevalence of atopic dermatitis (AD) has increased markedly in the United States over the past 5 decades, with current reports varying from 10% to 20% prevalence in US children, and new diagnoses are estimated at almost 11% per year. Recent research in AD pathophysiology and pathogenesis has demonstrated that AD is associated with epidermal barrier dysfunction and that mutations in the filaggrin gene are implicated in barrier defects. These discoveries hold promise for future breakthroughs in the diagnosis and management of AD.

KW - Atopic dermatitis pathogenesis

KW - Barrier defects

KW - Epidermal skin barrier

KW - Filaggrin gene

UR - http://www.scopus.com/inward/record.url?scp=84866841147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866841147&partnerID=8YFLogxK

U2 - 10.1016/j.sder.2012.07.002

DO - 10.1016/j.sder.2012.07.002

M3 - Article

VL - 31

JO - Seminars in Cutaneous Medicine and Surgery

JF - Seminars in Cutaneous Medicine and Surgery

SN - 1085-5629

IS - 3 SUPPL.

ER -